Larvol Delta - ASLAN-Pharmaceuticals-Enters-Into-a-Strategic-Licensing-Deal-With-Zenyaku-Kogyo-for-the-Development-and-Commercialization-of-Eblasakimab-in-Japan

eblasakimab (ASLAN004) - ASLAN Pharma, Zenyaku Holdings

https://www.globenewswire.com/news-release/2023/06/22/2692813/0/en/ASLAN-Pharmaceuticals-Enters-Into-a-Strategic-Licensing-Deal-With-Zenyaku-Kogyo-for-the-Development-and-Commercialization-of-Eblasakimab-in-Japan.html

Jun 22, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next